Chinese Pharma Company Launches Generics Of Lilly’s Zyprexa
This article was originally published in The Pink Sheet Daily
Executive Summary
Legal approach by Chinese firm could serve as roadmap for future patent disputes, lawyer tells PharmAsia News.